Intravitreal pegcetacoplan may be linked with increased incidence of exudative AMD

A post hoc analysis of the Phase 2 prospective, randomized, sham injection–controlled FILLY trial of pegcetacoplan for the treatment of geographic atrophy (GA) focused on participants who developed new-onset, investigator-determined exudative age-related macular degeneration (eAMD) during the trial.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553